This session was presented by Foley Partners Catherine Sun and Sharon Barner as well as Chen Meizhang, professor of Peking University, deputy council director of CNIPS (China Intellectual Property Society), director of Peking University IP Institute, and director of Peking University IPR Research Center.
Topics included:
- Different methods a non-Chinese technology-based company can employ to expand to China
- Chinese legal framework for each of the entry options
- Pros and cons of each option
- Role of Chinese regulatory bodies
Related Insights
July 30, 2025
Foley Viewpoints
CMS Finalizes Rule Change Applying Preponderance of the Evidence Standard to Agent, Broker, and Web-Broker Exchange Agreement Terminations for Cause
In its recently issued Final Rule (CMS-9884-F; 90 FR 27074-01; the Final Rule), the Centers for Medicare and Medicaid Services (CMS)…
July 30, 2025
Health Care Law Today
Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM): What You Need to Know About CMS’ Proposed Changes
On July 14, 2025, the Centers for Medicare and Medicaid Services (CMS) proposed key changes to remote patient monitoring (RPM) and remote…
July 30, 2025
Foley Viewpoints
US Considers Charging Fees Based on Patent Value
The Trump administration is reportedly considering a proposal to charge patent holders a fee based on the value of their patents,…